Evolving Practices in Low-Risk Papillary Thyroid Cancer: Impact of the 2015 ATA Guidelines
Current Oncology · 2026
DOI: 10.3390/curroncol33010026 ↗Kurz gefasst
Leitlinie in der Zeitschrift Current Oncology, 2026. Verfasst von Benard Gjeloshi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroidectomy, Thyroid Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The extent of initial surgical resection for low-risk papillary thyroid carcinoma (PTC) remains debated. Traditionally, total thyroidectomy (TT) has been the standard approach, although the 2015 American Thyroid Association (ATA) guidelines endorsed a more conservative strategy. The real-world adoption of these recommendations, however, is unclear. This study evaluated changes in the surgical management of low-risk PTC in a high-volume center following the implementation of the ATA guidelines and analyzed the impact on postoperative outcomes.
Methods
We conducted a retrospective study of 1644 patients who underwent surgery for localized low-risk PTC < 4 cm between 2014 and 2023. Temporal trends in the initial surgical procedure (TT vs. thyroid lobectomy [TL]) were analyzed overall and by tumor size and patient demographics. The need for completion thyroidectomy after TL and postoperative outcomes were also assessed.
Results
The use of TL increased from 0% in 2014 to 59.4% in 2023 (p < 0.001). For microcarcinomas, TL rose from 17.5% in 2016 to 78% in 2023, with similar but less pronounced trends for 1–2 cm tumors. TT remained predominant for nodules > 2 cm. The completion thyroidectomy rate declined from 32% in 2016 to 4% in 2022. Patients undergoing TT experienced higher rates of postoperative complications (12.4% vs. 3.0%), particularly transient hypoparathyroidism (8.9% vs. 0%), and permanent hypoparathyroidism (1.8% vs. 0%), as well as longer operative time and hospital stay (all p < 0.001). The incidence of hypoparathyroidism decreased over time as TL use increased.
Conclusions
Adoption of the 2015 ATA guidelines has progressively increased the use of TL in the management of low-risk PTC. This shift in surgical practice is associated with a reduction in the overall postoperative complication burden at the population level, largely driven by decreased hypoparathyroidism. Although guideline uptake has been gradual, current trends suggest increasing acceptance of less aggressive surgical strategies in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56124 Pisa, Italy.
ORCID-Profile: Marco Puccini, Gabriele Materazzi
Zitieren
APA
Gjeloshi, B., Rossi, L., Ambrosini, C. E., Becucci, C., Papini, P., Palma, A., De Napoli, L., Puccini, M., & Materazzi, G. (2026). Evolving Practices in Low-Risk Papillary Thyroid Cancer: Impact of the 2015 ATA Guidelines. Current Oncology. https://doi.org/10.3390/curroncol33010026
Vancouver
Gjeloshi B, Rossi L, Ambrosini CE, Becucci C, Papini P, Palma A, et al. Evolving Practices in Low-Risk Papillary Thyroid Cancer: Impact of the 2015 ATA Guidelines. Current Oncology. 2026. doi:10.3390/curroncol33010026
BibTeX
@article{Gjeloshi2026,
author = {Gjeloshi, Benard and Rossi, Leonardo and Ambrosini, Carlo Enrico and Becucci, Chiara and Papini, Piermarco and Palma, Andrea De and De Napoli, Luigi and Puccini, Marco and Materazzi, Gabriele},
title = {Evolving Practices in Low-Risk Papillary Thyroid Cancer: Impact of the 2015 ATA Guidelines},
journal = {Current Oncology},
year = {2026},
doi = {10.3390/curroncol33010026}
}
EUVIMED